TY - JOUR
T1 - Effect of metabolic syndrome on incidence of oral potentially malignant disorder
T2 - A prospective cohort study in Taiwan
AU - Siewchaisakul, Pallop
AU - Wang, Sen Te
AU - Peng, Szu Min
AU - Sarakarn, Pongdech
AU - Chen, Li Sheng
AU - Chen, Tony Hsiu Hsi
AU - Yeh, Yen Po
AU - Yen, Amy Ming Fang
N1 - Funding Information:
Funding This work was supported by Ministry of Science and Technology, Taiwan (MOST 108-2118-M-038-001-MY3 and MOST 108-2118-M-038-002-MY3).
Publisher Copyright:
© 2020 BMJ Publishing Group. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/10/14
Y1 - 2020/10/14
N2 - Objectives We aimed to assess the effect of metabolic syndrome (MetS) on incident oral potentially malignant disorder (OPMD). Design We conducted a prospective cohort study of the Changhua community-based integrated screening (CHCIS) programme and nationwide oral cancer screening programme during the period between 2005 and 2014. Setting CHCIS, Taiwan. Participants We enrolled 17 590 participants aged 30 years and older. Main outcomes and measures We assessed the impact of MetS on the outcome measured by incident OPMD. Results The incidences of OPMD among subjects with and without MetS were 7.68 ‰ and 5.38 ‰, respectively. After adjusting for confounders, subjects with MetS exhibited a statistically greater risk of developing OPMD compared with those who were free of MetS by 33% (adjusted rate ratio, aRR=1.33, 95% CI 1.14 to 1.55). Individual components of MetS still remained significant, including central obesity (aRR=1.22, 95% CI 1.04 to 1.44), hypertriglyceridaemia (aRR=1.26, 95% CI 1.07 to 1.49) and hyperglycaemia (aRR=1.20, 95% CI 1.02 to 1.41). Central obesity and hypertriglyceridaemia were also statistically associated with a subtype of OPMD, namely, leukoplakia. Conclusion The temporal influence of MetS on the risk of incident OPMD was noted in our prospective cohort study. Therefore, promoting an MetS prevention and control programme might reduce the occurrence of OPMD and oral cancer.
AB - Objectives We aimed to assess the effect of metabolic syndrome (MetS) on incident oral potentially malignant disorder (OPMD). Design We conducted a prospective cohort study of the Changhua community-based integrated screening (CHCIS) programme and nationwide oral cancer screening programme during the period between 2005 and 2014. Setting CHCIS, Taiwan. Participants We enrolled 17 590 participants aged 30 years and older. Main outcomes and measures We assessed the impact of MetS on the outcome measured by incident OPMD. Results The incidences of OPMD among subjects with and without MetS were 7.68 ‰ and 5.38 ‰, respectively. After adjusting for confounders, subjects with MetS exhibited a statistically greater risk of developing OPMD compared with those who were free of MetS by 33% (adjusted rate ratio, aRR=1.33, 95% CI 1.14 to 1.55). Individual components of MetS still remained significant, including central obesity (aRR=1.22, 95% CI 1.04 to 1.44), hypertriglyceridaemia (aRR=1.26, 95% CI 1.07 to 1.49) and hyperglycaemia (aRR=1.20, 95% CI 1.02 to 1.41). Central obesity and hypertriglyceridaemia were also statistically associated with a subtype of OPMD, namely, leukoplakia. Conclusion The temporal influence of MetS on the risk of incident OPMD was noted in our prospective cohort study. Therefore, promoting an MetS prevention and control programme might reduce the occurrence of OPMD and oral cancer.
KW - epidemiology
KW - oncology
KW - oral medicine
UR - http://www.scopus.com/inward/record.url?scp=85093477267&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85093477267&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2020-041971
DO - 10.1136/bmjopen-2020-041971
M3 - Article
C2 - 33055124
AN - SCOPUS:85093477267
SN - 2044-6055
VL - 10
JO - BMJ Open
JF - BMJ Open
IS - 10
M1 - e041971
ER -
